Safety Of DAPAGLIFLOZIN (FORXIGA) in Patient with Type 2 Diabetes Mellitus (T2dm) In Vietnam From A Post-Marketing Surveillance Program

Trial Identifier:	D1690R00038
Sponsor:	AstraZeneca
Start Date:	October 2017
Primary Completion Date:	March 2020
Study Completion Date:	March 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Vietnam	Ho Chi Minh, Vietnam

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.